Sunday September 27, 2020

Integumen in talks about potentially buying data analytics and biophysics firms

Integumen, which has developed an artificial skin for testing in labs instead of using animal skin, is looking at investing in a number of other areas to boost its business, it said last week.

Ian Guider

Markets Editor

@ianguider
21st March, 2019

Healthcare company Integumen is in talks about the potential acquisition of data analytics, software and biophysics companies.

Integumen, which has developed an artificial skin for testing in labs instead of using animal skin, is looking at investing in a number of other areas to boost its business, it said last week.

The company is backed by Gerard Brandon who set up the wound-care firm Alltracel, and his business partner Tony Richardson.

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

2 Yearly

€315

€248

Unlimited Access for 2 Years

This product does not auto-renew

Team Pass

Get a Business Account for you and your team

Related Stories

The way we did business a few months ago may never return – so the opportunity is to make changes that will both aid recovery and set us up well for our new futures

Tom Maguire | 4 months ago

What’s coming up today and what you might have missed

Hannah O’Brien | 9 months ago